MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

被引:133
作者
Buseyne, F
Le Gall, S
Boccaccio, C
Abastado, JP
Lifson, JD
Arthur, LO
Rivière, Y
Heard, JM
Schwartz, O [1 ]
机构
[1] Inst Pasteur, Unite Retrovirus & Transfert Genet, Paris, France
[2] Inst Pasteur, Lab Immunopathol Virale, Paris, France
[3] Inst Cordeliers, ImmunoDesigned Mol Res Labs, Paris, France
[4] NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
关键词
D O I
10.1038/85493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. This exogenous pathway may have a crucial role in the activation of CD8(+) cytotoxic T lymphocytes during human viral infections. We show here that HIV-1 epitopes derived from incoming virions are presented through the exogenous MHC-I pathway in primary human dendritic cells, and to a lower extent in macrophages, leading to cytotoxic T-lymphocyte activation in the absence of viral protein synthesis. Exogenous antigen presentation required adequate virus-receptor interactions and fusion of viral and cellular membranes. These results provide new insights into how anti-HIV cytotoxic T lymphocytes can be activated and have implications for anti-HIV vaccine design.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 45 条
[2]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[3]  
Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311
[4]   Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors [J].
Ayehunie, S ;
GarciaZepeda, EA ;
Hoxie, JA ;
Horuk, R ;
Kupper, TS ;
Luster, AD ;
Ruprecht, RM .
BLOOD, 1997, 90 (04) :1379-1386
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   TARGET CELL-SPECIFIC DETERMINANTS OF MEMBRANE-FUSION WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 3RD-VARIABLE REGION AND GP41 AMINO TERMINUS [J].
BERGERON, L ;
SULLIVAN, N ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2389-2397
[7]   T lymphocyte responses in HIV-1 infection: implications for vaccine development [J].
Brander, C ;
Walker, B .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) :451-459
[8]   Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: Inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells [J].
Buseyne, F ;
Fevrier, M ;
Garcia, S ;
Gougeon, ML ;
Riviere, Y .
VIROLOGY, 1996, 225 (01) :248-253
[9]   Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children [J].
Buseyne, F ;
Chaix, ML ;
Fleury, B ;
Manigard, O ;
Burgard, M ;
Blanche, S ;
Rouzioux, C ;
Rivière, Y .
VIROLOGY, 1998, 250 (02) :316-324
[10]   Dendritic cells and the replication of HIV-1 [J].
Cameron, P ;
Pope, M ;
GranelliPiperno, A ;
Steinman, RM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (02) :158-171